The production and supply in Canada are designed to address the growing need for no-carrier-added Lutetium-177 (n.c.a. Lu-177) in North America
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
AOI is the leading cancer hospital chain of South Asia operating 16 cancer hospitals in the region
The company will now be allowed to sell its proprietary and validated tinctures, gummies, and capsules across the UK
BDMP is a personalised program delivered through the Breathe app to assist people with Type 2 Diabetics to achieve healthy outcomes
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
The program, which has been active for over a decade, will now expand its reach, focusing on equitable access to education, resources, and community-driven solutions for patients and care partners
Allergan also presented new insights on the growing population of patients on GLP-1 agonists for weight loss who are seeking aesthetic treatments
The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology
The presentations underscore the company’s deep expertise in dermatology and immunology
Subscribe To Our Newsletter & Stay Updated
